Works matching DE "THERAPEUTIC use of RNA interference"
Results: 80
Zilebesiran Reduces SBP on Background SOC in Uncontrolled HTN: Daily Dose.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
Technology: Investment suggests RNAi is on the up.
- Published in:
- Nature, 2014, v. 510, n. 7503, p. 35, doi. 10.1038/510035b
- By:
- Publication type:
- Article
RNA interference rebooted.
- Published in:
- Nature, 2014, v. 508, n. 7497, p. 443, doi. 10.1038/508443a
- By:
- Publication type:
- Article
Gemellus.
- Published in:
- Colorectal Disease, 2012, v. 14, n. 12, p. 1560, doi. 10.1111/codi.12060
- Publication type:
- Article
Tolerogenic dendritic cells produced by lentiviral-mediated CD40- and interleukin-23p19-specific shRNA can ameliorate experimental autoimmune encephalomyelitis by suppressing T helper type 17 cells.
- Published in:
- Clinical & Experimental Immunology, 2014, v. 176, n. 2, p. 180, doi. 10.1111/cei.12266
- By:
- Publication type:
- Article
The small non-coding RNA response to virus infection in the Leishmania vector Lutzomyia longipalpis.
- Published in:
- PLoS Neglected Tropical Diseases, 2018, v. 12, n. 6, p. 1, doi. 10.1371/journal.pntd.0006569
- By:
- Publication type:
- Article
Significance and applications of nanoparticles in siRNA delivery for cancer therapy.
- Published in:
- Expert Review of Clinical Pharmacology, 2012, v. 5, n. 4, p. 403, doi. 10.1586/ECP.12.33
- By:
- Publication type:
- Article
Medical applications of RNA interference (RNAi).
- Published in:
- BMC Proceedings, 2013, v. 7, n. Suppl 2, p. 1, doi. 10.1186/1753-6561-7-S2-K21
- By:
- Publication type:
- Article
Comparative Transcriptome Analyses Uncover Key Candidate Genes Mediating Flight Capacity in Bactrocera dorsalis (Hendel) and Bactrocera correcta (Bezzi) (Diptera: Tephritidae).
- Published in:
- International Journal of Molecular Sciences, 2018, v. 19, n. 2, p. 396, doi. 10.3390/ijms19020396
- By:
- Publication type:
- Article
Development of Small RNA Delivery Systems for Lung Cancer Therapy.
- Published in:
- International Journal of Molecular Sciences, 2015, v. 16, n. 3, p. 5254, doi. 10.3390/ijms16035254
- By:
- Publication type:
- Article
RNA Interference-A Silent but an Efficient Therapeutic Tool.
- Published in:
- Applied Biochemistry & Biotechnology, 2013, v. 169, n. 6, p. 1774, doi. 10.1007/s12010-013-0098-1
- By:
- Publication type:
- Article
RNA interference technology with emphasis on delivery vehicles—prospects and limitations.
- Published in:
- Artificial Cells, Nanomedicine & Biotechnology, 2016, v. 44, n. 6, p. 1391, doi. 10.3109/21691401.2015.1058808
- By:
- Publication type:
- Article
Down-regulation of STAT3 expression using vector-based RNA interference promotes apoptosis in Hepatocarcinoma cells.
- Published in:
- Artificial Cells, Nanomedicine & Biotechnology, 2016, v. 44, n. 5, p. 1201, doi. 10.3109/21691401.2015.1029628
- By:
- Publication type:
- Article
Antiapoptotic Bcl-2 protein as a potential target for cancer therapy: A mini review.
- Published in:
- Artificial Cells, Nanomedicine & Biotechnology, 2016, v. 44, n. 5, p. 1212, doi. 10.3109/21691401.2015.1019668
- By:
- Publication type:
- Article
The antisense 5' end of the V2 gene confers enhanced resistance against the monopartite begomovirus cotton leaf curl Kokhran virus-Burewala strain.
- Published in:
- Acta Virologica, 2019, v. 63, n. 1, p. 26, doi. 10.4149/av_2019_101
- By:
- Publication type:
- Article
RNA interference-based therapeutics for inherited long QT syndrome (Review).
- Published in:
- Experimental & Therapeutic Medicine, 2015, v. 10, n. 2, p. 395, doi. 10.3892/etm.2015.2573
- By:
- Publication type:
- Article
Design of siRNA Therapeutics from the Molecular Scale.
- Published in:
- Pharmaceuticals (14248247), 2013, v. 6, n. 4, p. 440, doi. 10.3390/ph6040440
- By:
- Publication type:
- Article
Nanoparticle-Based Delivery of RNAi Therapeutics: Progress and Challenges.
- Published in:
- Pharmaceuticals (14248247), 2013, v. 6, n. 1, p. 85, doi. 10.3390/ph6010085
- By:
- Publication type:
- Article
Antiviral Stratagems Against HIV-1 Using RNA Interference (RNAi) Technology.
- Published in:
- Evolutionary Bioinformatics, 2013, n. 9, p. 203, doi. 10.4137/EBO.S11412
- By:
- Publication type:
- Article
Study of RNA Interference Targeting NET-1 Combination with Sorafenib for Hepatocellular Carcinoma Therapy In Vitro and In Vivo.
- Published in:
- Gastroenterology Research & Practice, 2013, p. 1, doi. 10.1155/2013/685150
- By:
- Publication type:
- Article
Overview of RNA interference therapeutics.
- Published in:
- Songklanakarin Journal of Science & Technology, 2012, v. 34, n. 3, p. 293
- By:
- Publication type:
- Article
Down-regulation of G protein-coupled receptor 137 by RNA interference inhibits cell growth of two hepatoma cell lines.
- Published in:
- Cell Biology International, 2015, v. 39, n. 4, p. 418, doi. 10.1002/cbin.10412
- By:
- Publication type:
- Article
Gene silencing in tick cell lines using small interfering or long double-stranded RNA.
- Published in:
- Experimental & Applied Acarology, 2013, v. 59, n. 3, p. 319, doi. 10.1007/s10493-012-9598-x
- By:
- Publication type:
- Article
Silencing of AP-4 inhibits proliferation, induces cell cycle arrest and promotes apoptosis in human lung cancer cells.
- Published in:
- Oncology Letters, 2016, v. 11, n. 6, p. 3735, doi. 10.3892/ol.2016.4451
- By:
- Publication type:
- Article
Combined RNAi targeting human Stat3 and ADAM9 as gene therapy for non-small cell lung cancer.
- Published in:
- Oncology Letters, 2016, v. 11, n. 2, p. 1242, doi. 10.3892/ol.2015.4018
- By:
- Publication type:
- Article
Oncolytic adenovirus-expressed RNA interference of O<sup>6</sup>-methylguanine DNA methyltransferase activity may enhance the antitumor effects of temozolomide.
- Published in:
- Oncology Letters, 2014, v. 8, n. 5, p. 2201, doi. 10.3892/ol.2014.2442
- By:
- Publication type:
- Article
The Utilization of RNA Silencing Technology to Mitigate the Voriconazole Resistance of Aspergillus Flavus; Lipofectamine-Based Delivery.
- Published in:
- Advanced Pharmaceutical Bulletin, 2017, v. 7, n. 1, p. 53, doi. 10.15171/apb.2017.007
- By:
- Publication type:
- Article
Update on the clinical utility of an RNA interference-based treatment: focus on Patisiran.
- Published in:
- Pharmacogenomics & Personalized Medicine, 2017, v. 10, p. 267, doi. 10.2147/PGPM.S87945
- By:
- Publication type:
- Article
Enzyme kinetics and distinct modulation of the protein kinase N family of kinases by lipid activators and small molecule inhibitors.
- Published in:
- Bioscience Reports, 2014, v. 34, n. 2, p. 93, doi. 10.1042/BSR20140010
- By:
- Publication type:
- Article
Correction to: The Race of 10 Synthetic RNAi-Based Drugs to the Pharmaceutical Market.
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice
Hemocompatibility Assessment of two siRNA Nanocarrier Formulations.
- Published in:
- Pharmaceutical Research, 2014, v. 31, n. 11, p. 3127, doi. 10.1007/s11095-014-1405-4
- By:
- Publication type:
- Article
Big pharma shows signs of renewed interest in RNAi drugs.
- Published in:
- Nature Medicine, 2014, v. 20, n. 2, p. 109, doi. 10.1038/nm0214-109
- By:
- Publication type:
- Article
CD22ΔE12 as a molecular target for RNAi therapy.
- Published in:
- British Journal of Haematology, 2015, v. 169, n. 3, p. 401, doi. 10.1111/bjh.13306
- By:
- Publication type:
- Article
Engineering Multifunctional RNAi Nanomedicine To Concurrently Target Cancer Hallmarks for Combinatorial Therapy.
- Published in:
- Angewandte Chemie, 2018, v. 130, n. 6, p. 1526, doi. 10.1002/ange.201710144
- By:
- Publication type:
- Article
ZFX regulates glioma cell proliferation and survival in vitro and in vivo.
- Published in:
- Journal of Neuro-Oncology, 2013, v. 112, n. 1, p. 17, doi. 10.1007/s11060-012-1032-z
- By:
- Publication type:
- Article
Knockdown of RLIP76 expression by RNA interference inhibits invasion, induces cell cycle arrest, and increases chemosensitivity to the anticancer drug temozolomide in glioma cells.
- Published in:
- Journal of Neuro-Oncology, 2013, v. 112, n. 1, p. 73, doi. 10.1007/s11060-013-1045-2
- By:
- Publication type:
- Article
Biodegradable Inorganic Nanovector: Passive versus Active Tumor Targeting in siRNA Transportation.
- Published in:
- Angewandte Chemie International Edition, 2016, v. 55, n. 14, p. 4582, doi. 10.1002/anie.201510844
- By:
- Publication type:
- Article
A Multi-RNAi Microsponge Platform for Simultaneous Controlled Delivery of Multiple Small Interfering RNAs.
- Published in:
- Angewandte Chemie International Edition, 2016, v. 55, n. 10, p. 3347, doi. 10.1002/anie.201508978
- By:
- Publication type:
- Article
SYNTHESIS AND CHARACTERIZATION OF GRP78 SIRNAS FOR SILENCING GENE EXPRESSION IN HEPG2 LIVER CARCINOMA CELLS.
- Published in:
- Bulletin: New Jersey Academy of Science, 2014, v. 59, n. 1, p. 1
- By:
- Publication type:
- Article
Evaluation and control of miRNA-like off-target repression for RNA interference.
- Published in:
- Cellular & Molecular Life Sciences, 2018, v. 75, n. 5, p. 797, doi. 10.1007/s00018-017-2656-0
- By:
- Publication type:
- Article
Nanotechnology: RNAi-based nanoparticles zap glioblastoma.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 1, p. 20, doi. 10.1038/nrd4214
- By:
- Publication type:
- Article
Trial watch: Pioneering RNAi therapy shows antitumour activity in humans.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 3, p. 178, doi. 10.1038/nrd3962
- By:
- Publication type:
- Article
EpCAM-targeted liposomal si-RNA delivery for treatment of epithelial cancer.
- Published in:
- Drug Delivery, 2016, v. 23, n. 4, p. 1101, doi. 10.3109/10717544.2014.973082
- By:
- Publication type:
- Article
Special Issue: Gene Therapy with Emphasis on RNA Interference.
- Published in:
- Viruses (1999-4915), 2015, v. 7, n. 8, p. 4482, doi. 10.3390/v7082830
- By:
- Publication type:
- Article
Insight into Alternative Approaches for Control of Avian Influenza in Poultry, with Emphasis on Highly Pathogenic H5N1.
- Published in:
- Viruses (1999-4915), 2012, v. 4, n. 11, p. 3179, doi. 10.3390/v4113179
- By:
- Publication type:
- Article
R049: Airway Injury Model for the Application of RNAi Therapy.
- Published in:
- 2006
- By:
- Publication type:
- Abstract
Silencing human genetic diseases with oligonucleotide-based therapies.
- Published in:
- Human Genetics, 2013, v. 132, n. 5, p. 481, doi. 10.1007/s00439-013-1288-1
- By:
- Publication type:
- Article
The impact of HIV-1 genetic diversity on the efficacy of a combinatorial RNAi-based gene therapy.
- Published in:
- Gene Therapy, 2015, v. 22, n. 6, p. 485, doi. 10.1038/gt.2015.11
- By:
- Publication type:
- Article
Silencing the FOP gene.
- Published in:
- Gene Therapy, 2012, v. 19, n. 7, p. 701, doi. 10.1038/gt.2011.190
- By:
- Publication type:
- Article
Disease-causing allele-specific silencing against the ALK2 mutants, R206H and G356D, in fibrodysplasia ossificans progressiva.
- Published in:
- Gene Therapy, 2012, v. 19, n. 7, p. 781, doi. 10.1038/gt.2011.193
- By:
- Publication type:
- Article